Reshma P. Shetty, See remarks at Ginkgo Bioworks Holdings, Inc. (DNA), sold 112,950 shares at $2.07 ($233K) on 2023-08-02, disclosed to the SEC on 2023-08-04.
Scheduled sale ($233k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.07 | 37,650 | $78K | 33.5% |
| 2 | $2.07 | 37,650 | $78K | 33.5% |
| 3 | $2.04 | 37,650 | $77K | 33.0% |
| Total | $2.06 avg | 112,950 | $233K | 100% |
| Filing → |
| DNA | SELL | 2023-12-22 | $133K | — | Filing → |
| DNA | SELL | 2023-12-15 | $173K | — | Filing → |
| DNA | SELL | 2023-12-08 | $99K | — | Filing → |